Rising hunger, waist growth, weight gain above about 2 lb per month, persistent heart-rate elevation, or declining strength indicate that the lower dose is not maintaining the prior response
"Lilly remains confident in the differentiated benefits of tirzepatide, the first and only dual GIP/GLP-1 receptor agonist approved to treat adults with obesity and adults with type two diabetes," the company said in an email statement to The Canadian Press
Semaglutide has 94% sequence homology to native human GLP-1 [3]
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: A post-treatment analysis of a randomised placebo-controlled trial
Its a naturally occurring amino acid that plays a crucial role in energy metabolism
10.1164/ajrccm.162.4.2003064